Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7780038 | TEVA BRANDED PHARM | Dispensing apparatus with dosage counter |
Jan, 2027
(3 years from now) | |
US10188811 | TEVA BRANDED PHARM | Nasal spray device |
Oct, 2031
(8 years from now) |
Market Authorisation Date: 23 March, 2012
Treatment: NA
Dosage: AEROSOL, METERED;NASAL
5
United States
4
European Union
3
China
3
Spain
2
Poland
2
Slovenia
2
United Kingdom
2
RS
2
Japan
2
Denmark
2
Croatia
2
Portugal
1
Chile
1
Peru
1
Canada
1
Korea, Republic of
1
Brazil
1
Hong Kong
1
Lithuania
1
Turkey
1
Germany
1
Hungary
1
Mexico
1
New Zealand
1
EA
1
Australia
1
San Marino
1
South Africa
1
Austria
1
Singapore
1
Israel
1
Cyprus
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10086156 | TEVA BRANDED PHARM | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
US9808587 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US11395889 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US10695512 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US10022510 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US10022509 | TEVA BRANDED PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
US9463289 | TEVA BRANDED PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US10561808 | TEVA BRANDED PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) |
Market Authorisation Date: 15 September, 2000
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8132712 | NORTON WATERFORD | Metered-dose inhaler |
Sep, 2028
(5 years from now) | |
US10695512 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US10022510 | NORTON WATERFORD | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
US10086156 | NORTON WATERFORD | Dose counter for inhaler and method for counting doses |
May, 2031
(7 years from now) | |
US10022509 | NORTON WATERFORD | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
US11395889 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
US8931476 | NORTON WATERFORD | Inhaler |
Jul, 2031
(8 years from now) | |
US10561808 | NORTON WATERFORD | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(8 years from now) | |
US11395888 | NORTON WATERFORD | Inhalers and related methods |
Jan, 2038
(14 years from now) | |
US10792447 | NORTON WATERFORD | Breath actuated inhaler |
Jan, 2039
(15 years from now) | |
US11559637 | NORTON WATERFORD | Inhalers and related methods |
Jul, 2039
(16 years from now) | |
US11583643 | NORTON WATERFORD | Inhalers and related methods |
Aug, 2041
(18 years from now) |
Market Authorisation Date: 03 August, 2017
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
36
United States
25
European Union
17
Hong Kong
17
Japan
16
China
15
Israel
14
Korea, Republic of
14
EA
13
Spain
11
Denmark
10
Poland
9
Canada
9
South Africa
6
Hungary
6
Portugal
4
Slovenia
4
United Kingdom
4
Cyprus
3
Brazil
3
Croatia
3
Mexico
3
San Marino
2
RS
2
Australia
1
India
1
New Zealand
1
Austria
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic